Notice of Extraordinary General Meeting - 28/08/2026
Filed with PSX · · 11 pages · English
Summary by 6ix AI
Citi Pharma Ltd. has issued a notice for an Extraordinary General Meeting to discuss special business, including a proposed alteration of its Memorandum of Association to include cannabis-related activities. The proposed amendment aims to broaden the company's business scope in the cannabis sector, subject to regulatory approvals. The notice includes details on voting procedures and other business matters to be addressed during the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Citi Pharma
- Chief Financial Officer - 07/08/2026
- Material Information - 08/07/2026
- Material Information - 21/05/2026
- Material Information - 06/05/2026
- Transmission of Quarterly Report for the Period Ended 31st March 2026 - 30/04/2026
Later from Citi Pharma
- Certified Copy of the Resolutions Adopted in the Extraordinary General Meeting held on 18 September 2026 - 18/09/2026
- Board Meeting - 28/09/2026
- Financial Results for the Year Ended 30 June 2026 - 05/10/2026
- Notice of Annual General Meeting (Prior to Publication) - 06/10/2026
- Notice of Annual General Meeting - Post Publication - 07/10/2026
Follow Citi Pharma into a list and get an email when it puts out news.
Follow Citi Pharma